Journal article
Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes
Abstract
BACKGROUND: We investigated whether intensive glycemic control, combination therapy for dyslipidemia, and intensive blood-pressure control would limit the progression of diabetic retinopathy in persons with type 2 diabetes. Previous data suggest that these systemic factors may be important in the development and progression of diabetic retinopathy.
METHODS: In a randomized trial, we enrolled 10,251 participants with type 2 diabetes who were at …
Authors
Chew EY; Ambrosius WT; Davis MD; Danis RP; Gangaputra S; Greven CM; Hubbard L; Esser BA; Lovato JF; Perdue LH
Journal
New England Journal of Medicine, Vol. 363, No. 3, pp. 233–244
Publisher
Massachusetts Medical Society
Publication Date
July 15, 2010
DOI
10.1056/nejmoa1001288
ISSN
0028-4793
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Antihypertensive AgentsCardiovascular DiseasesCholesterol, LDLDiabetes Mellitus, Type 2Diabetic RetinopathyDisease ProgressionDrug Therapy, CombinationDyslipidemiasFemaleFenofibrateFollow-Up StudiesGlycated HemoglobinHumansHyperglycemiaHypertensionHypoglycemic AgentsHypolipidemic AgentsMaleMiddle AgedSimvastatin